Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients – preliminary study

BACKGROUND: Fingolimod is a drug administered orally to adult patients treated for relapsing remitting course of multiple sclerosis (MS). Mode of action of fingolimod is based on intense S1P1 receptor stimulation and “arresting” lymphocytes in lymphatic organs. Objective of the research was to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudnicka, Julia, Czerwiec, Michał, Grywalska, Ewelina, Siwicka-Gieroba, Dorota, Walankiewicz, Monika, Grafka, Agnieszka, Zgurski, Michał, Surdacka, Agata, Bartosik-Psujek, Halina, Roliński, Jacek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Society of Experimental and Clinical Immunology 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655387/
https://www.ncbi.nlm.nih.gov/pubmed/26648781
http://dx.doi.org/10.5114/ceji.2015.54599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655387/
https://www.ncbi.nlm.nih.gov/pubmed/26648781
http://dx.doi.org/10.5114/ceji.2015.54599

Ejemplares similares